Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
A107852-5mg | 5mg | In stock | $77.90 | |
A107852-10mg | 10mg | In stock | $140.90 | |
A107852-25mg | 25mg | In stock | $290.90 | |
A107852-100mg | 100mg | In stock | $1,046.90 |
Vasoconstrictor peptide
Synonyms | CHEBI:131170 | CHEBI:48432 | HB3488 | HY-13948 | ty-10721 | Angiotensin II, ile(5)- | Q27293293 | 5-L-Isoleucineangiotensin II | Angiotensin II (acetate);Ang II (acetate);DRVYIHPF (acetate) | C50H71N13O12 | Angiotensinum II | Angiotensin 2 | Angiotensin I |
---|---|
Specifications & Purity | Moligand™, ≥90% |
Biochemical and Physiological Mechanisms | Angiotensin II is a crucial component of the Renin-Angiotensin System (RAS). It plays a vital role in vasoconstriction, regulating blood pressure, and controlling fluid balance by influencing the retention of sodium and water in the renal tubules. Further |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Product Description |
Sequence: H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IUPAC Name | (3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid |
---|---|
INCHI | InChI=1S/C50H71N13O12/c1-5-28(4)41(47(72)59-36(23-31-25-54-26-56-31)48(73)63-20-10-14-38(63)45(70)60-37(49(74)75)22-29-11-7-6-8-12-29)62-44(69)35(21-30-15-17-32(64)18-16-30)58-46(71)40(27(2)3)61-43(68)34(13-9-19-55-50(52)53)57-42(67)33(51)24-39(65)66/h6-8,11-12,15-18,25-28,33-38,40-41,64H,5,9-10,13-14,19-24,51H2,1-4H3,(H,54,56)(H,57,67)(H,58,71)(H,59,72)(H,60,70)(H,61,68)(H,62,69)(H,65,66)(H,74,75)(H4,52,53,55)/t28-,33-,34-,35-,36-,37-,38-,40-,41-/m0/s1 |
InChi Key | CZGUSIXMZVURDU-JZXHSEFVSA-N |
Canonical SMILES | CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N |
Isomeric SMILES | CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N |
WGK Germany | 3 |
RTECS | BW2165000 |
PubChem CID | 172198 |
Molecular Weight | 1046.18 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
H2318187 | Certificate of Analysis | Jul 15, 2023 | A107852 |
H2318188 | Certificate of Analysis | Jul 15, 2023 | A107852 |
H2318189 | Certificate of Analysis | Jul 15, 2023 | A107852 |
H2318190 | Certificate of Analysis | Jul 15, 2023 | A107852 |
A2310302 | Certificate of Analysis | Dec 01, 2022 | A107852 |
A2310303 | Certificate of Analysis | Dec 01, 2022 | A107852 |
A2310312 | Certificate of Analysis | Dec 01, 2022 | A107852 |
A2310316 | Certificate of Analysis | Dec 01, 2022 | A107852 |
A2310321 | Certificate of Analysis | Dec 01, 2022 | A107852 |
A2310322 | Certificate of Analysis | Dec 01, 2022 | A107852 |
A2310330 | Certificate of Analysis | Dec 01, 2022 | A107852 |
A2310332 | Certificate of Analysis | Dec 01, 2022 | A107852 |
G2226045 | Certificate of Analysis | Jun 05, 2022 | A107852 |
G2226046 | Certificate of Analysis | Jun 05, 2022 | A107852 |
I2129182 | Certificate of Analysis | Sep 18, 2021 | A107852 |
Solubility | insoluble in DMSO; insoluble in EtOH |
---|---|
Sensitivity | Heat Sensitive |
WGK Germany | 3 |
---|---|
RTECS | BW2165000 |
Starting at $300.90
Starting at $138.90
Starting at $339.90
Starting at $224.90
Starting at $83.90
Starting at $581.90
Starting at $95.90
Starting at $35.90
Starting at $32.90
Starting at $138.90
Starting at $72.90
Starting at $39.90
Starting at $190.90
Starting at $241.90
Starting at $69.90
1. Wang Meng-yang, Yu Tian-xiang, Wang Qin-yan, Han Xue, Hu Xiang, Ye Shi-ju, Long Xiao-hong, Wang Yi, Zhu Hong, Luo Wu, Liang Guang. (2023) OTUD1 promotes hypertensive kidney fibrosis and injury by deubiquitinating CDK9 in renal epithelial cells. ACTA PHARMACOLOGICA SINICA, (1-12). [PMID:38110583] |
2. Jiajia Zhang, Yu Tu, Jiajia Wei, Ruyi Zheng, Ji Shao, Qinhua Chen, Guang Liang, Huazhong Ying, Xue Han, Qiaojuan Shi. (2023) Dectin1 contributes to hypertensive vascular injury by promoting macrophage infiltration through activating the Syk/NF-κB pathway. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, (26): (166911). [PMID:37813169] |
3. Yushu Liu, Dong Wang, Yimin Jin, Guifang Sun, Qi Lou, Hong Wang, Weimin Li. (2023) Costunolide ameliorates angiotensin II-induced atrial inflammation and fibrosis by regulating mitochondrial function and oxidative stress in mice: A possible therapeutic approach for atrial fibrillation. MICROVASCULAR RESEARCH, (104600). [PMID:37666318] |
4. Wang Shuai, Bai Jie, Che Yilin, Qu Weikun, Li Jing. (2023) Fucoidan inhibits apoptosis and improves cardiac remodeling by inhibiting p53 transcriptional activation through USP22/Sirt 1. Frontiers in Pharmacology, 14 [PMID:37324479] |
5. Fangze Huang, Ximao Liu, Junjie Liu, Yu Xie, Li Zhao, Deshen Liu, Zifeng Zeng, Xiu Liu, Shaoyi Zheng, Zezhou Xiao. (2023) Phosphatidylethanolamine aggravates Angiotensin II-induced atrial fibrosis by triggering ferroptosis in mice. Frontiers in Pharmacology, 14 (1148410). [PMID:37288112] |
6. Mengyang Wang, Xue Han, Tianxiang Yu, Minxiu Wang, Wu Luo, Chunpeng Zou, Xiuyun Li, Gao Li, Gaojun Wu, Yi Wang, Guang Liang. (2023) OTUD1 promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytes. Theranostics, 13 (7): ( 2263–2280). [PMID:37153745] |
7. Tian-Lun Wen, Jia-Hui Bai, Ming-Mai Bao, Yong Qin, Yue Su, Yin-Long Guo. (2023) Ultrasonic sample introduction combined with flame assisted thermal ionization: Pretreatment-free direct mass spectrometry analysis for fraction collecting tubes of preparative liquid chromatography. TALANTA, 259 (124508). [PMID:37043878] |
8. Weiwei Zhu, Minxiu Wang, Leiming Jin, Bin Yang, Bin Bai, Rumbidzai Natasha Mutsinze, Wei Zuo, Nipon Chattipakorn, Joo Young Huh, Guang Liang, Yi Wang. (2022) Licochalcone A protects against LPS-induced inflammation and acute lung injury by directly binding with myeloid differentiation factor 2 (MD2). BRITISH JOURNAL OF PHARMACOLOGY, 180 (8): (1114-1131). [PMID:36480410] |
9. Siyuan Shen, Gaojun Wu, Wu Luo, Weixin Li, Xiaobo Li, Chengyi Dai, Weijian Huang, Guang Liang. (2023) Leonurine attenuates angiotensin II-induced cardiac injury and dysfunction via inhibiting MAPK and NF-κB pathway. PHYTOMEDICINE, 108 (154519). [PMID:36332391] |
10. Kai-Wen Ren, Xiao-Hong Yu, Yu-Hui Gu, Xin Xie, Yu Wang, Shi-hao Wang, Hui-Hua Li, Hai-Lian Bi. (2022) Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice. Frontiers in Cardiovascular Medicine, 9 (957903). [PMID:36304536] |
11. Na Yang, Chunpeng Zou, Wu Luo, Diyun Xu, Mengyang Wang, Yi Wang, Gaojun Wu, Peiren Shan, Guang Liang. (2022) Sclareol attenuates angiotensin II-induced cardiac remodeling and inflammation via inhibiting MAPK signaling. PHYTOTHERAPY RESEARCH, 37 (2): (578-591). [PMID:36178264] |
12. Yawen Deng, Zhitong Li, Xiangbo An, Rui Fan, Yao Wang, Jiatian Li, Xiaolei Yang, Jiawei Liao, Yunlong Xia. (2022) Hyperhomocysteinemia Promotes Cardiac Hypertrophy in Hypertension. Oxidative Medicine and Cellular Longevity, 2022 (1486157). [PMID:36046692] |
13. Xin Xie, Ting-ting Shen, Hai-lian Bi, Zhuo-lin Su, Zi-qi Liao, Ying Zhang, Lei Shi, Yun-long Xia. (2022) Melatonin inhibits angiotensin II–induced atrial fibrillation through preventing degradation of Ang II Type I Receptor–Associated Protein (ATRAP). BIOCHEMICAL PHARMACOLOGY, 202 (115146). [PMID:35710020] |
14. Mengyang Wang, Wu Luo, Tianxiang Yu, Shiqi Liang, Jinfeng Sun, Yi Zhang, Xue Han, Xiaohong Long, Guang Liang, Gao Li. (2022) Corynoline protects ang II-induced hypertensive heart failure by increasing PPARα and Inhibiting NF-κB pathway. BIOMEDICINE & PHARMACOTHERAPY, 150 (113075). [PMID:35658238] |
15. Guangquan Hu, Xiaojie Ding, Feng Gao, Jiehua Li. (2022) Calcium and integrin binding protein 1 (CIB1) induces myocardial fibrosis in myocardial infarction via regulating the PI3K/Akt pathway. EXPERIMENTAL ANIMALS, [PMID:34349085] |
16. Jinfu Qian, Wu Luo, Chengyi Dai, Jun Wang, Xinfu Guan, Chunpeng Zou, Nipon Chattipakorn, Gaojun Wu, Weijian Huang, Guang Liang. (2021) Myeloid differentiation protein 2 mediates angiotensin II-induced inflammation and mesenchymal transition in vascular endothelium. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1867 (166043). [PMID:33338595] |
17. Ke Lin, Wu Luo, Jueqian Yan, Siyuan Shen, Qirui Shen, Jun Wang, Xinfu Guan, Gaojun Wu, Weijian Huang, Guang Liang. (2021) TLR2 regulates angiotensin II-induced vascular remodeling and EndMT through NF-κB signaling. Aging-US, 13 (2): ( 2553–2574). [PMID:33318302] |
18. Zhengyong Wang, Yuqi Cao, Yingjie Lu, Fang Zhang, Yue Su, Yinlong Guo. (2020) Ultrasonic extraction and nebulization in real-time coupled with carbon fiber ionization mass spectrometry for rapid screening of the synthetic drugs adulterated into herbal products. ANALYTICA CHIMICA ACTA, 1136 (62). [PMID:33081950] |
19. Guo Xiao, Zhang Yongtao, Lu Changhong, Qu Fengxia, Jiang Xianyan. (2020) Protective effect of hyperoside on heart failure rats via attenuating myocardial apoptosis and inducing autophagy. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 84 (4): (714-724). [PMID:31797747] |
20. Rui Guo, Ningning Liu, Hao Liu, Junhua Zhang, Han Zhang, Yingchao Wang, Mirko Baruscotti, Lu Zhao, Yi Wang. (2020) High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3. PHYTOMEDICINE, 68 (153171). [PMID:32018211] |
21. Jing Yang, Wenpeng Zhang, Hongjun Zhang, Minlin Zhong, Wenbo Cao, Zishuai Li, Xi Huang, Zongxiu Nie, Jiaming Liu, Peng Li, Xiaoxiao Ma, Zheng Ouyang. (2019) Polydopamine-Modified Substrates for High-Sensitivity Laser Desorption Ionization Mass Spectrometry Imaging. ACS Applied Materials & Interfaces, 11 (49): (46140–46148). [PMID:31729222] |
22. Xin Xie, Hai-Lian Bi, Song Lai, Yun-Long Zhang, Nan Li, Hua-Jun Cao, Ling Han, Hong-Xia Wang, Hui-Hua Li. (2019) The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation. Science Advances, 5 (5): [PMID:31086810] |
23. Zheng Xu, Chunpeng Zou, Weihui Yu, Sujing Xu, Lan Huang, Zia Khan, Jingying Wang, Guang Liang, Yi Wang. (2019) Inhibition of STAT3 activation mediated by toll-like receptor 4 attenuates angiotensin II-induced renal fibrosis and dysfunction. BRITISH JOURNAL OF PHARMACOLOGY, 176 (14): (2627-2641). [PMID:30958891] |
1. Wang L et al.. (2021) Adropin inhibits the phenotypic modulation and proliferation of vascular smooth muscle cells during neointimal hyperplasia by activating the AMPK/ACC signaling pathway.. Exp Ther Med, 21 (6): (560). [PMID:33850532] |
2. Ageeva LV et al.. (2018) Data supporting that adipose-derived mesenchymal stem/stromal cells express angiotensin II receptors in situ and in vitro.. Data Brief, 16 (327-333). [PMID:29234689] |
3. Yang L et al.. (2017) Effect of AMPK signal pathway on pathogenesis of abdominal aortic aneurysms.. Oncotarget, 8 (54): (92827-92840). [PMID:29190959] |
4. Liu J et al.. (2022) Effects of angiotensin II combined with asparaginase and dexamethasone on the femoral head in mice: A model of steroid-induced femoral head osteonecrosis.. Front Cell Dev Biol, 10 (975879). [PMID:36187471] |
5. Bao Q et al.. (2020) Intermittent hypoxia mediated by TSP1 dependent on STAT3 induces cardiac fibroblast activation and cardiac fibrosis.. Elife, 9 [PMID:31934850] |
6. Yu C et al.. (2015) Knockdown of angiopoietin like-2 protects against angiotensin II-induced cerebral endothelial dysfunction in mice.. Am J Physiol Heart Circ Physiol, 308 (5): (H386-97). [PMID:25527773] |
7. Sysoeva VY et al.. (2017) Local angiotensin II promotes adipogenic differentiation of human adipose tissue mesenchymal stem cells through type 2 angiotensin receptor.. Stem Cell Res, 25 (115-122). [PMID:29127873] |
8. Li Q et al.. (2018) Megalin mediates plasma membrane to mitochondria cross-talk and regulates mitochondrial metabolism.. Cell Mol Life Sci, 75 (21): (4021-4040). [PMID:29916093] |
9. Guo J et al.. (2022) Metformin protects against abdominal aortic aneurysm by Atg7-induced autophagy.. Adv Clin Exp Med, 31 (59-69). [PMID:34714980] |
10. Wang Z et al.. (2019) Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE-/- mice.. Cell Biosci, 9 (68). [PMID:31467666] |
11. Wang D et al.. (2022) Quercetin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and activation of JAK2/STAT3 pathway: A target based networking pharmacology approach.. Front Pharmacol, 13 (1002363). [PMID:36324691] |
12. Yang L et al.. (2016) Silencing of hypoxia inducible factor-1a gene attenuated angiotensin ?-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice.. Atherosclerosis, 252 (40-49). [PMID:27497884] |
13. Xue H et al.. (2022) RIP3 Contributes to Cardiac Hypertrophy by Influencing MLKL-Mediated Calcium Influx.. Oxid Med Cell Longev, 2022 (5490553). [PMID:35464769] |
14. Duan J et al.. (2019) The cell-wide web coordinates cellular processes by directing site-specific Ca2+ flux across cytoplasmic nanocourses.. Nat Commun, 10 (2299). [PMID:31127110] |
15. Yang S et al.. (2019) The role of STAT3/mTOR-regulated autophagy in angiotensin II-induced senescence of human glomerular mesangial cells.. Cell Signal, 53 (327-338). [PMID:30389500] |
16. Wang Meng-yang, Yu Tian-xiang, Wang Qin-yan, Han Xue, Hu Xiang, Ye Shi-ju, Long Xiao-hong, Wang Yi, Zhu Hong, Luo Wu, Liang Guang. (2023) OTUD1 promotes hypertensive kidney fibrosis and injury by deubiquitinating CDK9 in renal epithelial cells. ACTA PHARMACOLOGICA SINICA, (1-12). [PMID:38110583] |
17. Jiajia Zhang, Yu Tu, Jiajia Wei, Ruyi Zheng, Ji Shao, Qinhua Chen, Guang Liang, Huazhong Ying, Xue Han, Qiaojuan Shi. (2023) Dectin1 contributes to hypertensive vascular injury by promoting macrophage infiltration through activating the Syk/NF-κB pathway. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, (26): (166911). [PMID:37813169] |
18. Yushu Liu, Dong Wang, Yimin Jin, Guifang Sun, Qi Lou, Hong Wang, Weimin Li. (2023) Costunolide ameliorates angiotensin II-induced atrial inflammation and fibrosis by regulating mitochondrial function and oxidative stress in mice: A possible therapeutic approach for atrial fibrillation. MICROVASCULAR RESEARCH, (104600). [PMID:37666318] |
19. Wang Shuai, Bai Jie, Che Yilin, Qu Weikun, Li Jing. (2023) Fucoidan inhibits apoptosis and improves cardiac remodeling by inhibiting p53 transcriptional activation through USP22/Sirt 1. Frontiers in Pharmacology, 14 [PMID:37324479] |
20. Fangze Huang, Ximao Liu, Junjie Liu, Yu Xie, Li Zhao, Deshen Liu, Zifeng Zeng, Xiu Liu, Shaoyi Zheng, Zezhou Xiao. (2023) Phosphatidylethanolamine aggravates Angiotensin II-induced atrial fibrosis by triggering ferroptosis in mice. Frontiers in Pharmacology, 14 (1148410). [PMID:37288112] |
21. Mengyang Wang, Xue Han, Tianxiang Yu, Minxiu Wang, Wu Luo, Chunpeng Zou, Xiuyun Li, Gao Li, Gaojun Wu, Yi Wang, Guang Liang. (2023) OTUD1 promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytes. Theranostics, 13 (7): ( 2263–2280). [PMID:37153745] |
22. Tian-Lun Wen, Jia-Hui Bai, Ming-Mai Bao, Yong Qin, Yue Su, Yin-Long Guo. (2023) Ultrasonic sample introduction combined with flame assisted thermal ionization: Pretreatment-free direct mass spectrometry analysis for fraction collecting tubes of preparative liquid chromatography. TALANTA, 259 (124508). [PMID:37043878] |
23. Weiwei Zhu, Minxiu Wang, Leiming Jin, Bin Yang, Bin Bai, Rumbidzai Natasha Mutsinze, Wei Zuo, Nipon Chattipakorn, Joo Young Huh, Guang Liang, Yi Wang. (2022) Licochalcone A protects against LPS-induced inflammation and acute lung injury by directly binding with myeloid differentiation factor 2 (MD2). BRITISH JOURNAL OF PHARMACOLOGY, 180 (8): (1114-1131). [PMID:36480410] |
24. Siyuan Shen, Gaojun Wu, Wu Luo, Weixin Li, Xiaobo Li, Chengyi Dai, Weijian Huang, Guang Liang. (2023) Leonurine attenuates angiotensin II-induced cardiac injury and dysfunction via inhibiting MAPK and NF-κB pathway. PHYTOMEDICINE, 108 (154519). [PMID:36332391] |
25. Kai-Wen Ren, Xiao-Hong Yu, Yu-Hui Gu, Xin Xie, Yu Wang, Shi-hao Wang, Hui-Hua Li, Hai-Lian Bi. (2022) Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice. Frontiers in Cardiovascular Medicine, 9 (957903). [PMID:36304536] |
26. Na Yang, Chunpeng Zou, Wu Luo, Diyun Xu, Mengyang Wang, Yi Wang, Gaojun Wu, Peiren Shan, Guang Liang. (2022) Sclareol attenuates angiotensin II-induced cardiac remodeling and inflammation via inhibiting MAPK signaling. PHYTOTHERAPY RESEARCH, 37 (2): (578-591). [PMID:36178264] |
27. Yawen Deng, Zhitong Li, Xiangbo An, Rui Fan, Yao Wang, Jiatian Li, Xiaolei Yang, Jiawei Liao, Yunlong Xia. (2022) Hyperhomocysteinemia Promotes Cardiac Hypertrophy in Hypertension. Oxidative Medicine and Cellular Longevity, 2022 (1486157). [PMID:36046692] |
28. Xin Xie, Ting-ting Shen, Hai-lian Bi, Zhuo-lin Su, Zi-qi Liao, Ying Zhang, Lei Shi, Yun-long Xia. (2022) Melatonin inhibits angiotensin II–induced atrial fibrillation through preventing degradation of Ang II Type I Receptor–Associated Protein (ATRAP). BIOCHEMICAL PHARMACOLOGY, 202 (115146). [PMID:35710020] |
29. Mengyang Wang, Wu Luo, Tianxiang Yu, Shiqi Liang, Jinfeng Sun, Yi Zhang, Xue Han, Xiaohong Long, Guang Liang, Gao Li. (2022) Corynoline protects ang II-induced hypertensive heart failure by increasing PPARα and Inhibiting NF-κB pathway. BIOMEDICINE & PHARMACOTHERAPY, 150 (113075). [PMID:35658238] |
30. Guangquan Hu, Xiaojie Ding, Feng Gao, Jiehua Li. (2022) Calcium and integrin binding protein 1 (CIB1) induces myocardial fibrosis in myocardial infarction via regulating the PI3K/Akt pathway. EXPERIMENTAL ANIMALS, [PMID:34349085] |
31. Jinfu Qian, Wu Luo, Chengyi Dai, Jun Wang, Xinfu Guan, Chunpeng Zou, Nipon Chattipakorn, Gaojun Wu, Weijian Huang, Guang Liang. (2021) Myeloid differentiation protein 2 mediates angiotensin II-induced inflammation and mesenchymal transition in vascular endothelium. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1867 (166043). [PMID:33338595] |
32. Ke Lin, Wu Luo, Jueqian Yan, Siyuan Shen, Qirui Shen, Jun Wang, Xinfu Guan, Gaojun Wu, Weijian Huang, Guang Liang. (2021) TLR2 regulates angiotensin II-induced vascular remodeling and EndMT through NF-κB signaling. Aging-US, 13 (2): ( 2553–2574). [PMID:33318302] |
33. Zhengyong Wang, Yuqi Cao, Yingjie Lu, Fang Zhang, Yue Su, Yinlong Guo. (2020) Ultrasonic extraction and nebulization in real-time coupled with carbon fiber ionization mass spectrometry for rapid screening of the synthetic drugs adulterated into herbal products. ANALYTICA CHIMICA ACTA, 1136 (62). [PMID:33081950] |
34. Guo Xiao, Zhang Yongtao, Lu Changhong, Qu Fengxia, Jiang Xianyan. (2020) Protective effect of hyperoside on heart failure rats via attenuating myocardial apoptosis and inducing autophagy. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 84 (4): (714-724). [PMID:31797747] |
35. Rui Guo, Ningning Liu, Hao Liu, Junhua Zhang, Han Zhang, Yingchao Wang, Mirko Baruscotti, Lu Zhao, Yi Wang. (2020) High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3. PHYTOMEDICINE, 68 (153171). [PMID:32018211] |
36. Jing Yang, Wenpeng Zhang, Hongjun Zhang, Minlin Zhong, Wenbo Cao, Zishuai Li, Xi Huang, Zongxiu Nie, Jiaming Liu, Peng Li, Xiaoxiao Ma, Zheng Ouyang. (2019) Polydopamine-Modified Substrates for High-Sensitivity Laser Desorption Ionization Mass Spectrometry Imaging. ACS Applied Materials & Interfaces, 11 (49): (46140–46148). [PMID:31729222] |
37. Xin Xie, Hai-Lian Bi, Song Lai, Yun-Long Zhang, Nan Li, Hua-Jun Cao, Ling Han, Hong-Xia Wang, Hui-Hua Li. (2019) The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation. Science Advances, 5 (5): [PMID:31086810] |
38. Zheng Xu, Chunpeng Zou, Weihui Yu, Sujing Xu, Lan Huang, Zia Khan, Jingying Wang, Guang Liang, Yi Wang. (2019) Inhibition of STAT3 activation mediated by toll-like receptor 4 attenuates angiotensin II-induced renal fibrosis and dysfunction. BRITISH JOURNAL OF PHARMACOLOGY, 176 (14): (2627-2641). [PMID:30958891] |